Expression of miR-155 in CD14+ PBM in RA patients is higher than in HC and miR155 is involved in overexpression of chemokines (CCL) CCL3, CCL4, CCL5, CCL8 and chemokine receptor (CCR) CCR2 and CCR7. The gene discussed is CD14; the disease is rheumatoid arthritis.